MAPT and Alzheimer disease: Alzheimer’s disease is considered a metabolic disorder, with metabolic disturbances contributing directly to Alzheimer’s disease through various pathways, including synaptic disconnection, neuronal loss, accumulation of amyloid-β, and hyperphosphorylation of tau protein (de la Monte, 2014).